Literature DB >> 30442369

Long noncoding RNA MAGI2-AS3 regulates CCDC19 expression by sponging miR-15b-5p and suppresses bladder cancer progression.

Feng Wang1, Yanwen Zu2, Shibin Zhu3, Yu Yang4, Weiping Huang4, Hui Xie4, Gonghui Li5.   

Abstract

Bladder cancer (BCa) belongs to a popular urological malignancy and leads to large numbers of deaths worldwide. Recently, emerging evidences indicate that long noncoding RNAs (lncRNAs) are closely related with BC occurrence and progression. However, the function of lncRNA MAGI2-AS3 remains poorly understood in BC. In this present study, we screened out a novel lncRNA MAGI2-AS3 whose expression was downregulated in BCa tissues. We showed that MAGI2-AS3 downregulation in BCa patients indicated a poor prognosis. Functionally, we showed that MAGI2-AS3 overexpression inhibits proliferation, migration and invasion of BCa cells. Moreover, ectopic expression of MAGI2-AS3 suppresses BCa growth in vivo. Bioinformatics analysis revealed that MAGI2-AS3 could serve as a competing endogenous RNA (ceRNA) for miR-15b-5p. In the meantime, miR-15b-5p directly targeted CCDC19, a tumor suppressor in BCa. Rescue assays demonstrated that knockdown of CCDC19 restored the proliferation, migration and invasion of BCa cells suppressed by MAGI2-AS3 overexpression. In conclusion, this study identified a novel mechanism that MAGI2-AS3/miR-15b-5p/CCDC19 signaling pathway regulates BCa progression.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bladder cancer; CCDC19; MAGI2-AS3; Progression; miR-15b-5p

Mesh:

Substances:

Year:  2018        PMID: 30442369     DOI: 10.1016/j.bbrc.2018.11.013

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  LincRNA-p21 suppresses glutamine catabolism and bladder cancer cell growth through inhibiting glutaminase expression.

Authors:  Qun Zhou; Hengji Zhan; Fan Lin; Yuhan Liu; Kang Yang; Qunjun Gao; Mengting Ding; Yuchen Liu; Weiren Huang; Zhiming Cai
Journal:  Biosci Rep       Date:  2019-04-12       Impact factor: 3.840

2.  Integrative transcriptome data mining for identification of core lncRNAs in breast cancer.

Authors:  Xiaoming Zhang; Jing Zhuang; Lijuan Liu; Zhengguo He; Cun Liu; Xiaoran Ma; Jie Li; Xia Ding; Changgang Sun
Journal:  PeerJ       Date:  2019-10-07       Impact factor: 2.984

3.  LncRNA MAGI2-AS3 is downregulated in non-small cell lung cancer and may be a sponge of miR-25.

Authors:  Yutong Sui; Wencheng Chi; Li Feng; Jiakang Jiang
Journal:  BMC Pulm Med       Date:  2020-03-05       Impact factor: 3.317

4.  Long Noncoding MAGI2-AS3 Suppresses Several Cellular Processes of Lung Squamous Cell Carcinoma Cells by Regulating miR-374a/b-5p/CADM2 Axis.

Authors:  Jia He; Xiaoyun Zhou; Li Li; Zhijun Han
Journal:  Cancer Manag Res       Date:  2020-01-15       Impact factor: 3.989

5.  Long Non-Coding RNA MAGI2-AS3 is a New Player with a Tumor Suppressive Role in High Grade Serous Ovarian Carcinoma.

Authors:  Priyanka Gokulnath; Tiziana de Cristofaro; Ichcha Manipur; Tina Di Palma; Amata Amy Soriano; Mario Rosario Guarracino; Mariastella Zannini
Journal:  Cancers (Basel)       Date:  2019-12-12       Impact factor: 6.639

6.  Long non-coding RNA PCAT6 regulates bladder cancer progression via the microRNA-143-3p/PDIA6 axis.

Authors:  Yuanjie Zhang; Lin Chen; Gang Luo
Journal:  Exp Ther Med       Date:  2021-07-01       Impact factor: 2.447

7.  LncRNA MAGI2-AS3 is involved in cervical squamous cell carcinoma development through CDK6 up-regulation.

Authors:  Qifang Liu; Shuang Liu; Xiaoying Wang; Jin Zhang; Kuiran Liu
Journal:  Infect Agent Cancer       Date:  2019-11-20       Impact factor: 2.965

8.  LncRNA MAGI2-AS3 is down-regulated in intervertebral disc degeneration and participates in the regulation of FasL expression in nucleus pulposus cells.

Authors:  Shuting Cui; Zizhen Liu; Bin Tang; Zhizhen Wang; Baojian Li
Journal:  BMC Musculoskelet Disord       Date:  2020-03-06       Impact factor: 2.362

9.  lncRNA MAGI2-AS3 Prevents the Development of HCC via Recruiting KDM1A and Promoting H3K4me2 Demethylation of the RACGAP1 Promoter.

Authors:  Jian Pu; Jianchu Wang; Huamei Wei; Tao Lu; Xianjian Wu; Yi Wu; Zesheng Shao; Chunying Luo; Yan Lu
Journal:  Mol Ther Nucleic Acids       Date:  2019-08-28       Impact factor: 8.886

10.  LncRNA MAGI2-AS3 Is Regulated by BRD4 and Promotes Gastric Cancer Progression via Maintaining ZEB1 Overexpression by Sponging miR-141/200a.

Authors:  Dandan Li; Jingjie Wang; Meixin Zhang; Xinhui Hu; Jiajun She; Xuemei Qiu; Xudong Zhang; Li Xu; Ying Liu; Shanshan Qin
Journal:  Mol Ther Nucleic Acids       Date:  2019-11-15       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.